How to Switch to the Wegovy Pill From Injections UK 2026
Since the Wegovy pill (oral semaglutide) was approved on 11 June 2026, many patients on weekly injections want to switch to a needle-free daily tablet. This guide explains how each switch works, why the two are different, what to expect, and what your prescriber needs to know for a smooth transition.
Why the Type of Switch Matters
The two switches are not the same, because they involve different medicines:
- Wegovy injection → Wegovy pill: the same active ingredient (semaglutide), just a different form.
- Mounjaro → Wegovy pill: a different active ingredient (tirzepatide → semaglutide), which is a bigger clinical change.
Switching From the Wegovy Injection → Pill
This is the more straightforward switch because both are semaglutide.
- No washout usually needed — same molecule, so no drug to clear first.
- Timing: you typically start the tablet around when your next weekly injection would have been due.
- Starting strength: chosen by your prescriber based on your current injection dose and tolerability — not a fixed conversion. Absorption differs between forms, so you won’t necessarily match milligram-for-milligram.
- Day to day: you move from one weekly injection to one daily tablet, taken on an empty stomach with the 30-minute wait.
Switching From Mounjaro → Pill
This is a bigger change because you’re moving to a different molecule.
- Washout required — a gap (commonly around 7 days) after your last Mounjaro injection before your first tablet. Two GLP-1 medicines must not overlap.
- Appetite may feel different — Mounjaro acts on two hunger hormones (GLP-1 and GIP); the pill acts on one (GLP-1). Some people notice slightly less appetite suppression and discuss this with their prescriber.
- Starting strength: judged by your prescriber from your Mounjaro dose, tolerability and progress — not a simple dose-for-dose swap.
What to Tell Your Prescriber
- Your current medication and exact dose (Wegovy injection or Mounjaro).
- How long you’ve been on it and the date of your last injection.
- Any side effects and how well you tolerate your current dose.
- Your reason for switching — needles, routine, tolerability or clinical.
With this, your prescriber confirms a safe starting strength, any washout gap, and the right day to take your first tablet.
Switch Safely — Prescriber-Confirmed
Your Slinic prescriber sets your exact starting dose at your free video consultation. Wegovy pill from £92.00/month · No subscription · GPhC No. 1033729
Frequently Asked Questions
Can I switch from the Wegovy injection to the pill?
Yes, under prescriber supervision. Because both are semaglutide, no washout is usually needed and you typically start the tablet when your next injection would have been due. Your prescriber confirms the starting strength.
Can I switch from Mounjaro to the Wegovy pill?
Yes, but it’s a bigger change because they’re different molecules. A washout gap of around 7 days after your last Mounjaro injection is usually required, and your prescriber confirms your starting strength.
Is there a dose conversion chart for switching?
No — there’s no manufacturer-published dose-equivalence protocol for switching to the oral form for weight loss. Your starting strength is a clinical decision made by your prescriber, never self-selected.
Do I need a washout period to switch?
From the Wegovy injection, usually not (same molecule). From Mounjaro, yes — commonly around 7 days, because it’s a different molecule.
Will I lose progress by switching?
Switching is designed to continue your treatment without a gap. Your prescriber times it to avoid interruption and confirms an appropriate dose to maintain your progress.
Related Guides
- Wegovy Pill UK 2026: Full Guide
- Wegovy Pill vs Injection
- Wegovy Pill vs Mounjaro
- Wegovy Pill Dosing Guide
References
- Wharton S, et al. Oral Semaglutide 25 mg (OASIS 4). N Engl J Med 2025;393:1077–1087.
- NHS — Semaglutide medicine information.
- GPhC Register — verify Slinic (Reg No. 1033729).
This guide is for general information and does not replace personalised medical advice. Semaglutide and tirzepatide are prescription-only medicines and must be prescribed and supervised by a registered healthcare professional. Never switch treatments without prescriber supervision. Individual results vary.
